Conservative commentator Charlie Kirk shot and killed at Utah event
Investing.com - Morgan Stanley has raised its price target on Oracle (NYSE:ORCL) to $246.00 from $175.00 while maintaining an Equalweight rating on the stock. The company, currently trading at $232.80, has seen impressive returns with a 66% gain over the past year and maintains a strong market position with a $654 billion market capitalization.
The investment bank’s analysis suggests Oracle could revise its fiscal year 2029 revenue target to approximately $125 billion at the company’s upcoming Analyst Day.
Despite the potential for higher revenue, Morgan Stanley notes that building gross margin pressure implies earnings per share of $11.50 to $12.00.
The firm believes that assuming a Microsoft-type multiple, the potential upside for Oracle appears to be already priced into the stock.
Morgan Stanley maintains its Equalweight stance on Oracle as it awaits greater visibility on the company’s long-term margins.
In other recent news, Oracle has seen a series of significant developments. Global Equities Research has increased its price target for Oracle to $400, maintaining an Overweight rating, citing Oracle’s strong position in Context Engineering as a major AI catalyst. Additionally, Mizuho raised its price target to $300, emphasizing Oracle’s role as a "structural AI winner" and expressing confidence in its growth trajectory. Financing news includes a $38 billion debt package led by JPMorgan Chase and Mitsubishi UFJ Financial Group to fund Oracle’s data centers in Wisconsin and Texas, with a $23 billion loan already committed for the Texas campus. Furthermore, NYC Health + Hospitals is expanding its use of Oracle Fusion Cloud Applications to modernize its operations, indicating Oracle’s growing influence in the healthcare sector. Citizens JMP has reiterated a Market Outperform rating with a $315 price target, supported by positive feedback from industry executives and former employees. These developments highlight Oracle’s ongoing strategic moves and market positioning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.